一个移动应用程序 (Meds@HOME) 的有效性,以提高医疗复杂性的儿童的药物安全:随机对照试验的协议
Nicole E Werner1, Makenzie Morgen2, Sophie Kooiman2
1Indiana University School of Public Health-Bloomington, Bloomington, IN, United States.
JMIR research protocols
|September 9, 2024
概括
移动应用程序Meds@HOME显示了改善医疗复杂性的儿童的护理人员药物管理准确性的承诺. 这项干预旨在减少不良药物事件,并加强慢性护理管理.
科学领域:
- 儿科医疗保健服务 儿科医疗保健服务
- 数字健康干预措施 数字健康干预措施
- 药物的安全性 药物的安全性
背景情况:
- 患有医疗复杂性 (CMC) 的儿童需要谨慎的药物管理.
- 护理人员药物管理错误可能导致不良药物事件.
- Meds@HOME应用程序是与家庭和卫生专业人员共同设计的,以支持护理人员.
研究的目的:
- 为了试点测试Meds@HOME移动应用程序干预.
- 评估Meds@HOME对初级护理人员 (PCG) 和二级护理人员 (SCG) 药物管理准确性的有效性.
主要方法:
- 一项试点随机对照试验,涉及高达152个PCG和304个SCG的高风险药物CMC.
- 在6个月的试验中,PCG被随机分配给Meds@HOME干预组或对照组.
- 主要结局:PCG药物给药的准确性 (指示,配方,剂量,频率,途径).
主要成果:
- 招聘正在进行中,截至2024年5月15日,有62%的PCG已注册.
- 该研究预计将于2025年1月28日完成,预计结果将于2025年底完成.
- 该协议包括招募SCG的新方法.
结论:
- Meds@HOME应用程序是提高CMC药物安全的一个有希望的策略.
- 该应用程序有可能改善慢性护理管理并减少不良药物事件.
- 未来的使用可能会扩展到各种护理网络,用于复杂的药物治疗程序.
相关概念视频
01:28Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
01:21Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
01:19Pharmacovigilance
788
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
788